Nova Ahrens
About Nova Ahrens
Nova Ahrens serves as the Director of Financial Planning and Analysis at EyePoint Pharmaceuticals, where she has worked since 2018. She specializes in Gross-to-Net Revenue Forecasting, government submissions, and financial reporting.
Work at EyePoint Pharmaceuticals
Nova Ahrens has served as the Director of Financial Planning and Analysis at EyePoint Pharmaceuticals since 2018. In this role, she is responsible for Gross-to-Net Revenue Forecasting and managing government submissions. Ahrens has led the implementation of the Adaptive management reporting and planning tool, enhancing the company's financial processes. She prepares presentations for the Board of Directors that include Profit & Loss and Cash Flow projections, which are critical for evaluating the company's cash burn.
Education and Expertise
Nova Ahrens holds a Bachelor of Business Administration (BBA) in Accounting from Rider University. She furthered her education at Fairleigh Dickinson University, where she earned a Master's degree in Finance. Her academic background provides a strong foundation for her expertise in financial planning and analysis, enabling her to effectively contribute to her role at EyePoint Pharmaceuticals.
Background
Before joining EyePoint Pharmaceuticals, Nova Ahrens developed her skills in financial analysis and planning. Her educational qualifications in Accounting and Finance have equipped her with the necessary tools to excel in her current position. Ahrens has a solid understanding of financial forecasting and budgeting, which she applies in her day-to-day responsibilities.
Achievements
In her role at EyePoint Pharmaceuticals, Nova Ahrens authors variance commentaries for both the Annual Budget and Quarterly Forecasts. This involves analyzing financial data to provide insights and explanations regarding budget variances, which is essential for strategic financial planning. Her contributions in this area support the company's financial decision-making processes.